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Summary.-We have developed a technique for the immunocytochemical staining of
marrow smears using antiserum to epithelial membrane antigen (EMA). This mem-
brane component is confined to, but widely distributed in, epithelial tissues and
tumours derived from them, and is strongly expressed by infiltrating breast car-
cinoma cells. Marrow aspirates from patients with both early and metastatic breast
cancer have been examined, and the results of immunocytochemical staining com-
pared with conventional cytology and histology. Staining with antiserum to EMA
enabled us to detect small numbers of carcinoma cells, and increased the yield of
positive samples. Furthermore, using this technique, we found malignant cells in the
marrow of patients with primary breast cancer with no other evidence of metastatic
disease. Thus immunocytochemical staining for EMA may be ofvalue in the detection
of micrometastases in patients with primary breast carcinoma.
THE LOCALIZATION of a cell-surface com-
ponent, which has been called epi-
thelial membrane antigen (EMA), has
been described in both normal and neo-
plastic tissue, using an antiserum raised
against human milk-fat-globule mem-
branes (Heyderman et al., 1979; Sloane &
Ormerod, 1981). In formalin-fixed paraffin-
embedded sections, the antigen is confined
to, but widely distributed in, epithelial
tissues and tumours derived from them.
Primary and metastatic breast carcinomas
almost always express the antigen (Sloane
& Ormerod, 1981) and single cells in
infiltrates have been found to stain
especially strongly with antisera to EMA.
Normal and neoplastic, haemopoietic,
lymphoid, osseous and other connective
tissues do not express EMA.
Antiserum to EMA has been used to
facilitate detection of micrometastases in
histological tissue section. Examination of
blocks of marrow aspirates from patients
with metastatic breast cancer led to the
identification of single malignant cells,
which increased the yield of positive
samples by 21% (Sloane et al., 1980).
When only small numbers of malignant
cells are present, taking a section from a
tissue block introduces considerable samp-
ling errors. Diagnostic yield might further
improve by using the antiserum on mar-
row smears, when the entire aspirated
sample may be examined.
In this paper we describe a method of
preparing marrow aspirates in a form
suitable forsubsequentimmunocytochemi-
cal staining, and demonstrate the value
of antisera to EMA in identifying marrow
metastases in patients with breast cancer.
PATIENTS AND METHODS
Patients-Seventy-four marrow aspirates
from 71 patients with breast cancer wereD. P. DEARNALEY ET AL.
examined. At the time of sampling patients
fell into 3 categories:
(1) 20 patients with primary cancer without
evidence of metastatic spread,
(2) 10 patients without evidence of meta-
stases when undergoing staging investigations
during follow-up after primary treatment; and
(3) 44 patients with metastatic breast
cancer, including 24 with bone metastases.
All these patients were staged as previously
described (Coombes et al., 1980). Bone meta-
stases were diagnosed after radiological
skeletal survey and isotope bone scan using
99mtechnetium diphosphonate.
Marrow aspirates.-All aspirates were ob-
tained from the posterior iliac crest. Air-dried
smears were made for routine cytological
examination and subsequently stained auto-
matically with May-Grunwald Giemsa stain.
An aliquot of the remaining sample was pro-
cessed for immunocytochemistry, and the rest
ofthe aspirate was fixed, embedded, sectioned
and stained with haematoxylin and eosin
(Luke's preparation) as previously described
(Sloane et al., 1980).
Preparation of marrow aspirates for irnmu-
nocytochemical staining. It was found that
routinely prepared marrow smears failed
to stain with anti-EMA, despite the presence
of obvious clumps of carcinoma cells. This
was thought to be due to a failure of primary
and/or secondary antiserum to diffuse through
layers of dried marrow aspirate. If red cells
were removed and thin smears prepared,
strong staining of carcinoma cells was appar-
ent. Removal of red cells could be effected
either by lysis with ammonium chloride
or by density separation using a solution of
Ficoll and sodium metrizoate (Boyum, 1968).
The latter method gave more reliable results,
and was chosen for this study. A density of
1-077 wAas found suitable (Lymphoprep;
Nyegaard); most malignant cells were re-
tained at the interface, together with many
cells of the lymphoid series, megakaryocytes,
and variable numbers of erythroid and
myeloid precursors. The spun pellet contained
erythrocytes, inormoblasts and some cells of
the myeloid series, together with damaged
cells. Adequate -washing of cells before
smearing was necessary to prevent back-
ground staining ofnon-cellular material.
About 0-3 ml ofmarrow, aspirate was taken
directly into 0-5 ml Hepes-buffered TC119
medium with 100 u of sterile heparin. This
cell suspension was layered on to 10 ml of
Lymphoprep in a 30ml Sterilin Universal
container and spun at 400 g for 20 min. The
cell layer at the interface was aspirated,
washed twice with TC119 and azide-free.
phosphate-buffered saline (PBS). The washed
pellet was gently pipetted to disaggregate
clumps of loosely cohesive cells. Thin smears
were made and fixed immediately in 100%
ethanol for 2 h. Smears were stored at room
temperature in the dark before staining;
deterioration of antigen was not observed
over a 2-week period, but storage in the
dark at -20°C is recommended for longer
intervals.
Immunohistochemical stain.-Ethanol-fixed
smears were first treated wAith 2 28% periodic
acid in distilled water for 10 min, followed
by 0-02% 0 fresh sodium borohydride for a
further 2 min. These reagents have been
found empirically to abolish nonspecific
staining of some haemopoietic cells by the
alkaline phosphatase-conjugated second anti-
body. The smears were next immersed in
20% acetic acid for 10 min to block endo-
genous alkaline phosphatase present in osteo-
blasts and leucocytes, and then washed in
PBS. Staining was performed using rabbit
anti-EMA at a suitable dilution for 90 min,
followed by sheep anti-rabbit alkaline-phos-
phatase-conjugated second antibody for a
further 90 min. Sections were washe(d in
PBS betwreen these two steps. Dilutions of
both first and second antibodies were made
in 1:20 non-immnune goat serum and were
determined by staining tissue sections of
breast carcinomas and smears of breast-
carcinoma cell lines. Alkaline phosphatase
was visualized using naphthol AS: BI and
Brentamine Fast Red TR as substrates for
1 h, after which sections were washed in
distilled water and counterstained with
Mayer's haemalum for 30 min. To confirm
antibody specificity human breast-carcinoma
sections were incubated with anti-serum
which had been absorbed with a preparation
of EMA (Sloane et al., 1980; Sloane &
Ormerod, 1981): staining activity was
completely abolished.
Alkaline-phosphatase conjugates were pre-
ferred to those using horseradish peroxidase
as they appear to give more dependable
results, and because the technique for block-
ing endogenous enzyme has less damaging
effects on cytological detail. It was also found
to be visually easier to screen smears with a
red rather than a brown reaction product.
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FIG. 1.-Indirect immuno-alkaline pliosphatase stain for EMA on marrow smear, showing a clump
of breast-carcinoma cells with strong membrane accentuation. x 600.
FIG. 2.- Clump of cells showing granular pattern of positivity to EMA. Membrane accentuation is
not apparent and the aspirate was classified as EMA-suspicious (±). Luke's preparation contained
a single tumour clump. x 600.
FIG. 3. Single EMA+ cell in marrow smear. Conventional methods showed no evidence of marrow
infiltration. x 600.
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Smears stained with anti-EMA were read
(D.D., J.P.S.) writhout knowledge of the
patient's clinical state or of the results of the
Giemsa or Luke's preparations.
RESULTS
On the smears stained with anti-EMA,
clumps of cells, which on morphological
grounds could be identified as malignant,
gave a strongly positive reaction. The
cytoplasm wAas heavily stained, with mem-
brane accentuation (Fig. 1). Single cells
showing the same characteristics of stain-
ing and morphology were also found (Fig.
3). These aspirates were recorded as
EMA+. On some smears, there were cells
or clumps of cells in which the morphology
or staining was obscured by overlying
cells, or the membrane accentuation was
absent. An example is shown in Fig. 2,
where a clump of cells shows granular
staining without membrane accentuation;
in this case the Luke's preparation showed
a single small clump of carcinoma. In the
absence ofother EMA+ cells, such aspirates
were recorded as suspicious.
In total, EMA+ cells were identified in
15 aspirates, and suspicious cells or clumps
( ± ) were present in a further 6 (Tables
I & II). Malignant cells were seen in 8
aspirates by Giemsa or Luke's preparation.
Samples from all but 2 of these patients
contained EMA+ cells; of these, one had
cells categorized as suspicious, and the
other sample was very small (Table III).
The presence and distribution of meta-
stases in patients with positive marrow
samples is shown in Table II. Most patients
with marrow metastases (whether demon-
strated conventionally or by anti-EMA
staining) had bone deposits revealed by
TABLE I. Comnparison of anti-EMA,
Giemsa, and Luke's Preparations in
detecting marrow infiltration in 74 biopsy
samples
EiIA Gicnmsa Luko's*
+ 15
6
53
6
3
65
5
0
66
TABLE II.-Clinical state of breast-cancer
patients and detection of marrow infiltra-
tion using either antiserum to EMA or
conventional methods
EAMA
Total,
No. + +
Giemsa/
Luke's
+ ±
Primary, no
metastases* 20 1 1 0
Post-primary, no
metastases* 10 1 0 0
Bone metastases 24 9 3 6
Metastases (not bone) 20 4 2? 2
Total 74 15 6 8
* For screening teehniques, see Patients
Alethods.
0
0
3
andl
skeletal survey or bone scan. Six patients
had EMA+ cells in the marrow, without
demonstrable bone metastases, and 2 of
these were without metastases at any site,
including 1 patient with primary breast
cancer involving axillary lymph nodes.
Many smears stained with anti-EMA con-
tained a very small number of positive
cells. These cells were individually counted
and their total nunmber compared with the
detection of infiltration by conventional
techniques (Table III). Aspirates contain-
ing > 100 EMA+ cells per smear were all
detected by conventional morphological
methods, whereas only 2/11 aspirates con-
taining <100 EMA+ cells were detected
from Luke's or Giemsa preparations. The
2 patients without evidence of dissemina-
ted cancer had < 5 EMA+ cells per smear.
In one patient with an EMA smear con-
taining about 20 positive cells, conven-
tional methods were negative. On repeat
aspiration 4 months later, > 100 positive
TABLE III.-Relationship of number of
EMA+ cells to the detection of marrow
infiltration by Giemsa or Luke's pre-
parations
EMAA cells/
smear
> 100
5-100
l-5
Suspicious (.< 5)
No.
5
3
7
1
Giemsa t
5
0*
0*
0*
Luke's*
4/4
0
0
0
* lnia(lequate samples in 3 patients.
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cells per smear were seen, and both Giemsa
and Luke's preparations contained malig-
nant cells.
DISCUSSION
We have succeeded in devising a method
ofpreparing marrow aspirates for immuno-
cytochemical staining that gives smears
of sufficiently high standard for the recog-
nition of small numbers of malignant
EMA+ cells. Our previous work had shown
that an increased diagnostic yield resulted
from anti-EMA staining of sections from
blocks of marrow aspirates (Sloane et al.,
1980) but it was felt that the diagnostic
potential of this method was limited,
because a section only allows examination
of a small part ofthe sample.
It was necessary to remove erythrocytes
from marrow aspirates in order to obtain
immunocytochemical staining, and this
was best achieved by density centrifuga-
tion on Lymphoprep. This also had the
advantage of removing damaged cells
which may stain nonspecifically, and pro-
duced an enrichment of the malignant cell
population by removing some erythroid
precursors and many cells of the myeloid
series.
The method assumes that EMA+ cells
in marrow are malignant. This has not
been proved conclusively but considerable
evidence from previous work has shown
that EMA is only expressed by cells of
epithelial or mesothelial derivation (Hey-
derman et al., 1979; Sloane & Ormerod,
1981). In the present study it was found
that: (1) EMA+ cells were commonest
when the marrow aspirate was shown to
be malignant by conventional techniques;
(2) patients with skeletal metastases had
a higher incidence of EMA+ cells in
marrow; (3) patients without known
metastases had very few EMA+ cells in
their marrow; and (4) EMA+ cells had
cytological features unlike normal marrow
precursor cells and entirely consistent
with metastatic breast carcinoma.
Marrow sampling has been used to
detect metastatic breast cancer by many
authors. Positive samples have been ob-
tained in 28-43% of patients with meta-
static breast cancer, though the technique
has not been found helpful in staging
patients with primary disease (Riddell &
Landys, 1979; Leland & Macpherson,
1979; Ingle et al., 1978; Coombes et al.,
1980). The increased diagnostic yield using
trephine biopsy together with marrow
aspirates has been stressed (Ingle et al.,
1978; Contreras et al., 1972; Bearden et al.,
1974; Leland & Macpherson, 1979; Jam-
shidi & Swaim, 1971; Ellis et al., 1964)
but as this is at least in part due to diffi-
culty in aspirating carcinoma cells from
scirrhous tumour masses (Leland & Mac-
pherson, 1979) it may be ofless importance
when attempting to detect truly micro-
metastatic infiltration. Our series of mar-
row aspirates revealed positive or sus-
picious cells in 19/44 (430o) of metastatic
patients, but also in 3/30 (10%) ofpatients
without conventionally demonstrable
metastases at any site, including 2/20
(10%) who had primary breast carcinomas
with involved axillary nodes. Although
the application of immunohistochemical
staining with anti-EMA in marrow tre-
phines might further increase diagnostic
yield in patients with metastatic breast
cancer, this would be of little clinical
consequence.
The finding of small numbers of EMA+
cells in the marrow of patients apparently
free of metastases is of more interest, and
requires further investigation and evalua-
tion as to its prognostic significance. It
may be possible to identify a group of
poor-risk primary breast-cancer patients
by directly demonstrating micrometastatic
spread. Since multiple marrow biopsies
have been shown to increase diagnostic
yield in metastatic carcinoma (Brunning
et al., 1975) we plan to evaluate the role
of anti-EMA staining of multiple marrow
samples in patients with primary breast
carcinoma. W!e shall also compare the
efficacy of trephine biopsy and aspirate in
detecting small volumes oftumour infiltra-
tion. Further studies are in hand to evalu-
ate the use of anti-EMA staining of mar-
rows in patients with equivocal skeletal
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surveys or bone scans. The techniques
described may also be suitable for evaluat-
ing marrow infiltration by carcinomas
from many other primary sites.
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